LEADER 02766nam  22004575  450 
001 9910872187903321
005 20240705125517.0
010   $a9783031588037$b(electronic bk.)
010   $z9783031588020
024 7 $a10.1007/978-3-031-58803-7
035   $a(MiAaPQ)EBC31518800
035   $a(Au-PeEL)EBL31518800
035   $a(CKB)32674598400041
035   $a(DE-He213)978-3-031-58803-7
035   $a(EXLCZ)9932674598400041
100   $a20240705d2024      u|         0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aClinical Trials in Age-Related Macular Degeneration Treatment /$fby Jeffrey N. Weiss
205   $a1st ed. 2024.
210  1$aCham :$cSpringer Nature Switzerland :$cImprint: Springer,$d2024.
215   $a1 online resource (300 pages)
300   $aIncludes index.
311 08$aPrint version: Weiss, Jeffrey N. Clinical Trials in Age-Related Macular Degeneration Treatment Cham : Springer International Publishing AG,c2024 9783031588020 
327   $aPart 1: Introduction -- Chapter 1. Introduction to Age-Related Macular Degeneration -- Chapter 2. Tables -- Part 2: Stem Cell Studies -- Chapter 3. United States -- Chapter 4. Caribbean -- Chapter 5. China -- Chapter 6. Great Britain -- Part 3: Gene Therapy Trials -- Chapter 7. United States -- Chapter 8. Canada -- Chapter 9. China -- Part 4: Other Trials -- Chapter 10. United States -- Chapter 11. Australia -- Chapter 12. Austria -- Chapter 13. China -- Chapter 14. Italy -- Chapter 15. Korea -- Chapter 15. Norway -- Chapter 16. South America -- Chapter 17. Thailand.
330   $aThis book is a compendium of the worldwide ocular stem cell, gene therapy, pharmaceutical, and other miscellaneous studies treating Age-Related Macular Degeneration registered with Clinicaltrials.gov. Clinicaltrials.gov is the largest website listing of registered clinical research studies in the world. The study and the clinical trial numbers are provided in order to make it easier for the reader to obtain further information. The book also includes an introduction on Age-Related Macular Degeneration as well as analysis of the clinical studies. Clinical Trials in Age-Related Macular Degeneration Treatment is a valuable resource for ophthalmologists, optometrists, other physicians, and researchers.
606   $aOphthalmology
606   $aOphthalmology
615  0$aOphthalmology.
615 14$aOphthalmology.
676   $a617.735
700   $aWeiss$b Jeffrey N.$0927848
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
912   $a9910872187903321
996   $aClinical Trials in Age-Related Macular Degeneration Treatment$94174519
997   $aUNINA